Loss of lysyl oxidase in adipose tissue ameliorates metabolic inflexibility induced by high‐fat diet
Obesity · 2025
DOI: 10.1002/oby.24253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2025. Verfasst von Yun-Qian Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic…. Hauptthemen laut MEDLINE: Diet, High-Fat, Protein-Lysine 6-Oxidase, Adipose Tissue, Brown, Adipose Tissue. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Systemic administration of β‐aminopropionitrile to inhibit lysyl oxidase (Lox) activity improves metabolism, but it exhibits a broad spectrum of effects. Clarification of the role of Lox in adipose tissue metabolism under high‐fat diet (HFD) conditions is needed.
Methods
Mice with adipose tissue knockout of Lox (Lox AKO ) and wild‐type mice were subjected to a 16‐week HFD regimen. A detailed evaluation encompassing adipose tissue, hepatic function, and systemic metabolism was conducted. RNA sequencing analysis was used to unravel the intricate mechanisms behind the metabolic enhancements in Lox AKO mice.
Results
Compared with the control, although there was no difference in body weight, Lox AKO mice exhibited an improved metabolic phenotype, including enhanced insulin sensitivity, improved glucose tolerance, and reduced liver steatosis, along with reduced adipose tissue inflammation and fibrosis. Lox AKO mice showed increased thermogenic activity in brown adipose tissue with increased uncoupling protein 1 (UCP1) expression and oxygen consumption rate. Additionally, RNA sequencing analysis revealed that adipose deletion of Lox might facilitate the metabolic processing of glucose, branched‐chain amino acids, and fatty acids in brown adipose tissue.
Conclusions
These findings indicate that adipocyte Lox deletion improves metabolic adaptability under an HFD, highlighting Lox as a promising therapeutic target for obesity‐associated metabolic disorders. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Metabolism and Molecular Medicine of the Ministry of Education, Department of Biochemistry and Molecular Biology of School of Basic Medical Sciences, Fudan University, Shanghai, People's Republic of Ch…
ORCID-Profile: Yun-Qian Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Y. Q., Chang, X. Y., Yang, L., Pan, D., & Huang, H. Y. (2025). Loss of lysyl oxidase in adipose tissue ameliorates metabolic inflexibility induced by high‐fat diet. Obesity. https://doi.org/10.1002/oby.24253
Vancouver
Zhou YQ, Chang XY, Yang L, Pan D, Huang HY. Loss of lysyl oxidase in adipose tissue ameliorates metabolic inflexibility induced by high‐fat diet. Obesity. 2025. doi:10.1002/oby.24253
BibTeX
@article{Zhou2025,
author = {Zhou, Yun-Qian and Chang, Xin-Yue and Yang, Lei and Pan, Dongning and Huang, Hai-Yan},
title = {Loss of lysyl oxidase in adipose tissue ameliorates metabolic inflexibility induced by high‐fat diet},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.24253}
}
EUVIMED